Amphiphilic Aminoglycosides as Medicinal Agents

Area of Science:

• Medicinal Chemistry
• Antimicrobial Drug Development
• Molecular Biology

Background:

• Aminoglycosides (AGs) are antibiotics targeting ribosomal RNA.
• Conjugating hydrophobic groups to AGs creates amphiphilic aminoglycosides (AAGs).
• AAGs exhibit broad-spectrum antibacterial effects by targeting bacterial membranes.

Purpose of the Study:

• To review the identification and development of broad-spectrum antibacterial AAGs.
• To explore AAGs' structure-activity relationships and cytotoxicity.
• To summarize recent advances in AAGs, including antibiotic hybrids.

Main Methods:

• Synthesis and characterization of amphiphilic aminoglycosides.
• Evaluation of antibacterial activity against susceptible and resistant strains.
• Analysis of structure-activity and structure-cytotoxicity relationships.

Main Results:

• AAGs demonstrate potent antibacterial activity against multidrug-resistant bacteria.
• Targeting bacterial membranes (LPS and cardiolipin) is a key mechanism.
• Emergence of resistance in *Pseudomonas aeruginosa* to AAGs is difficult.
• AAGs show potential as antibiotic hybrids and drug delivery vehicles.

Conclusions:

• AAGs represent a promising new class of antibiotic agents targeting bacterial membranes.
• Further research into AAGs' structure-activity relationships can optimize their development.
• AAGs offer a viable strategy to combat antibiotic resistance.